EFFICACY AND SAFETY OF PIROZADIL IN LONG-TERM ADMINISTRATION - A STUDY OF POST-MARKETING SURVEILLANCE

被引:0
|
作者
TAPOUNET, R
机构
来源
MEDICINA CLINICA | 1987年 / 89卷 / 20期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:858 / 860
页数:3
相关论文
共 50 条
  • [31] Long-Term Safety and Efficacy of Teneligliptin in Elderly Patients with Type 2 Diabetes: Subgroup Analysis of a 3-Year Post-Marketing Surveillance in Japan
    Kadowaki, Takashi
    Haneda, Masakazu
    Ito, Hiroshi
    Sasaki, Kazuyo
    Yamada, Yuka
    ADVANCES IN THERAPY, 2020, 37 (05) : 2477 - 2492
  • [32] Long-Term Safety and Efficacy of Teneligliptin in Elderly Patients with Type 2 Diabetes: Subgroup Analysis of a 3-Year Post-Marketing Surveillance in Japan
    Takashi Kadowaki
    Masakazu Haneda
    Hiroshi Ito
    Kazuyo Sasaki
    Yuka Yamada
    Advances in Therapy, 2020, 37 : 2477 - 2492
  • [33] Safety/Efficacy of Prucalopride in Korean Patients with Chronic Constipation: Post-marketing Surveillance
    Yeon, Sang Eun
    Kim, Su Youn
    Chung, Woo Chul
    Jeon, Seong Woo
    Park, Soo Jung
    Choi, Chang Hwan
    Choi, Myung Gyu
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2021, 78 (04): : 219 - 226
  • [34] Long-term tolerability and effectiveness of raltegravir in Japanese patients: Results from post-marketing surveillance
    Kuroishi, Naho
    Watananbe, Asuka
    Sakuma, Ryuta
    Ruzicka, Daniel J.
    Hara, Mitsuyoshi
    PLOS ONE, 2019, 14 (01):
  • [35] Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes Mellitus: A 3-Year Post-Marketing Surveillance Study
    Yamamoto, Fumiko
    Unno, Yuriko
    Okamura, Tomoo
    Ikeda, Rie
    Ochiai, Kaori
    Hayashi, Naoyuki
    DIABETES THERAPY, 2020, 11 (01) : 107 - 117
  • [36] Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes Mellitus: A 3-Year Post-Marketing Surveillance Study
    Fumiko Yamamoto
    Yuriko Unno
    Tomoo Okamura
    Rie Ikeda
    Kaori Ochiai
    Naoyuki Hayashi
    Diabetes Therapy, 2020, 11 : 107 - 117
  • [37] POST-MARKETING SURVEILLANCE
    ROBSON, RH
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 25 (03) : 404 - 404
  • [38] Long-term safety of enzyme replacement therapy with agalsidase alfa in patients with Fabry disease: post-marketing extension surveillance in Japan
    Arakawa, Makoto
    Ikeda, Yoshinori
    Otaka, Hiromichi
    Iwashiro, Sanghun
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2024, 40
  • [39] POST-MARKETING SURVEILLANCE
    SULLMAN, SF
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1979, 72 (01) : 65 - 66
  • [40] Long-Term Safety and Effectiveness of Adalimumab in Japanese Patients with Noninfectious Intermediate, Posterior, or Panuveitis: Post-Marketing Surveillance of 251 Patients
    Kenichi Namba
    Toshikatsu Kaburaki
    Hidekazu Tsuruga
    Yohei Ogawa
    Eri Iwashita
    Hiroshi Goto
    Ophthalmology and Therapy, 2022, 11 : 1147 - 1161